ED
DXC icon

Exane Derivatives’s DXC Technology DXC Stock Holding History

Exane Derivatives’s Portfolio DXC Stock Details DXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30
Closed -$640 – 843
2020
Q3 		$535 Sell
30
-115,318
-100% -$2.1M ﹤0.01% 670
2020
Q2 		$1.9M Buy
115,348
+7,098
+7% +$113K 0.51% 61
2020
Q1 		$1.41M Buy
108,250
+10,452
+11% +$276K 0.39% 62
2019
Q4 		$3.39M Buy
97,798
+97,719
+123,695% +$3.19M 0.63% 56
2019
Q3 		$2.33K Sell
79
-1,309
-94% -$55.8K ﹤0.01% 479
2019
Q2 		$76.5K Sell
1,388
-55,880
-98% -$3.23M 0.01% 358
2019
Q1 		$3.68M Buy
+57,268
New +$3.66M 0.73% 48
2017
Q3 		– Sell
-31,970
Closed -$2.12M – 595
2017
Q2 		$2.12M Buy
+31,970
New +$2.12M 0.46% 58

Other funds holding DXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's DXC Position: Q4 2020 in Review

Exane Derivatives sold out of DXC Technology (DXC) in Q4 2020, closing a stake of 30 shares — an estimated $640 sold.

Exane Derivatives first reported a position in DXC in Q2 2017 and held it in 8 quarters. The position peaked at $3.68M in Q1 2019. 555 funds tracked by Wall St. Rank hold DXC as of Q4 2020.

  • Exane Derivatives reported no remaining DXC Technology position as of Q4 2020 after selling out during the quarter.
  • Exane Derivatives sold 30 DXC Technology shares in Q4 2020, an estimated $640.
  • Exane Derivatives first reported a position in DXC Technology in Q2 2017 and held it in 8 quarters.
  • Exane Derivatives's DXC Technology position peaked at $3.68M in Q1 2019.
  • 555 funds tracked by Wall St. Rank held DXC Technology as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.